Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Biology|August 27, 2021
Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune CellsMarie Colombe Agahozo, Marcel Smid, Ronald van Marion, et al.
Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
BMJ Open|September 7, 2021
Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trialElles M F van de Voort, Gerson M Struik, Linetta B Koppert, et al.
Cancer Research|November 23, 2016
T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid TumorsTeresa Manzo, Tabea Sturmheit, Veronica Basso, et al.
Neuro-Oncology Advances|July 10, 2020
Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapyZineb Belcaid, Cor Berrevoets, John Choi, et al.
European Urology Oncology|April 29, 2025
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort AnalysisDebbie G J Robbrecht, Youssra Salhi, John W M Martens, et al.
Cancers|March 29, 2023
Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon RadiotherapyShweta Mahajan, Hayri E Balcioglu, Astrid Oostvogels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2026
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in bloodKarlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLsLinda Wooldridge, Mathew Clement, Anna Lissina, et al.
Nature Medicine|April 20, 2010
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapyGavin M Bendle, Carsten Linnemann, Anna I Hooijkaas, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Biology|August 27, 2021
Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune CellsMarie Colombe Agahozo, Marcel Smid, Ronald van Marion, et al.
Nature Communications|January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytomaLevi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
BMJ Open|September 7, 2021
Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trialElles M F van de Voort, Gerson M Struik, Linetta B Koppert, et al.
Cancer Research|November 23, 2016
T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid TumorsTeresa Manzo, Tabea Sturmheit, Veronica Basso, et al.
Neuro-Oncology Advances|July 10, 2020
Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapyZineb Belcaid, Cor Berrevoets, John Choi, et al.
European Urology Oncology|April 29, 2025
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort AnalysisDebbie G J Robbrecht, Youssra Salhi, John W M Martens, et al.
Cancers|March 29, 2023
Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon RadiotherapyShweta Mahajan, Hayri E Balcioglu, Astrid Oostvogels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2026
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in bloodKarlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLsLinda Wooldridge, Mathew Clement, Anna Lissina, et al.
Nature Medicine|April 20, 2010
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapyGavin M Bendle, Carsten Linnemann, Anna I Hooijkaas, et al.
Pageof 14